USA Thebaine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Thebaine market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Thebaine market. Detailed analysis of key players, along with key growth strategies adopted by Thebaine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Taj Pharmaceuticals

    • API Labs

    • Alcaliber

    • Tasmanian Alkaloids

    • TPI

    • Cepia-Sanofi

    • Mallinckrodt Pharmaceuticals

    • Noramco

    • Faran Shimi Pharmaceuticals

    • Gansu Alkaloids

    • Hwells

    By Type:

    • Food Grade

    • Pharmaceutical Grade

    By End-User:

    • Oxymorphone

    • Nalbuphine

    • Naltrexone

    • Buprenorphine

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Thebaine Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Thebaine Market Size and Growth Rate of Food Grade from 2016 to 2027

      • 1.3.2 USA Thebaine Market Size and Growth Rate of Pharmaceutical Grade from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Thebaine Market Size and Growth Rate of Oxymorphone from 2016 to 2027

      • 1.4.2 USA Thebaine Market Size and Growth Rate of Nalbuphine from 2016 to 2027

      • 1.4.3 USA Thebaine Market Size and Growth Rate of Naltrexone from 2016 to 2027

      • 1.4.4 USA Thebaine Market Size and Growth Rate of Buprenorphine from 2016 to 2027

      • 1.4.5 USA Thebaine Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Thebaine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Thebaine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Thebaine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Thebaine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Thebaine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Thebaine by Major Types

      • 3.4.1 Market Size and Growth Rate of Food Grade

      • 3.4.2 Market Size and Growth Rate of Pharmaceutical Grade

    4 Segmentation of Thebaine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Thebaine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Thebaine in Oxymorphone

      • 4.4.2 Market Size and Growth Rate of Thebaine in Nalbuphine

      • 4.4.3 Market Size and Growth Rate of Thebaine in Naltrexone

      • 4.4.4 Market Size and Growth Rate of Thebaine in Buprenorphine

      • 4.4.5 Market Size and Growth Rate of Thebaine in Others

    5 Market Analysis by Regions

    • 5.1 USA Thebaine Production Analysis by Regions

    • 5.2 USA Thebaine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Thebaine Landscape Analysis

    • 6.1 West USA Thebaine Landscape Analysis by Major Types

    • 6.2 West USA Thebaine Landscape Analysis by Major End-Users

    7 South USA Thebaine Landscape Analysis

    • 7.1 South USA Thebaine Landscape Analysis by Major Types

    • 7.2 South USA Thebaine Landscape Analysis by Major End-Users

    8 Middle West USA Thebaine Landscape Analysis

    • 8.1 Middle West USA Thebaine Landscape Analysis by Major Types

    • 8.2 Middle West USA Thebaine Landscape Analysis by Major End-Users

    9 Northeast USA Thebaine Landscape Analysis

    • 9.1 Northeast USA Thebaine Landscape Analysis by Major Types

    • 9.2 Northeast USA Thebaine Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Taj Pharmaceuticals

        • 10.1.1 Taj Pharmaceuticals Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 API Labs

        • 10.2.1 API Labs Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Alcaliber

        • 10.3.1 Alcaliber Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Tasmanian Alkaloids

        • 10.4.1 Tasmanian Alkaloids Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 TPI

        • 10.5.1 TPI Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Cepia-Sanofi

        • 10.6.1 Cepia-Sanofi Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Mallinckrodt Pharmaceuticals

        • 10.7.1 Mallinckrodt Pharmaceuticals Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Noramco

        • 10.8.1 Noramco Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Faran Shimi Pharmaceuticals

        • 10.9.1 Faran Shimi Pharmaceuticals Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Gansu Alkaloids

        • 10.10.1 Gansu Alkaloids Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Hwells

        • 10.11.1 Hwells Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Thebaine Market Size and Growth Rate of Food Grade from 2016 to 2027

    • Figure USA Thebaine Market Size and Growth Rate of Pharmaceutical Grade from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Thebaine Market Size and Growth Rate of Oxymorphone from 2016 to 2027

    • Figure USA Thebaine Market Size and Growth Rate of Nalbuphine from 2016 to 2027

    • Figure USA Thebaine Market Size and Growth Rate of Naltrexone from 2016 to 2027

    • Figure USA Thebaine Market Size and Growth Rate of Buprenorphine from 2016 to 2027

    • Figure USA Thebaine Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Thebaine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Thebaine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Thebaine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Thebaine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Thebaine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Thebaine

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Thebaine by Different Types from 2016 to 2027

    • Table Consumption Share of Thebaine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Food Grade

    • Figure Market Size and Growth Rate of Pharmaceutical Grade

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Thebaine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Thebaine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oxymorphone

    • Figure Market Size and Growth Rate of Nalbuphine

    • Figure Market Size and Growth Rate of Naltrexone

    • Figure Market Size and Growth Rate of Buprenorphine

    • Figure Market Size and Growth Rate of Others

    • Table USA Thebaine Production by Regions

    • Table USA Thebaine Production Share by Regions

    • Figure USA Thebaine Production Share by Regions in 2016

    • Figure USA Thebaine Production Share by Regions in 2021

    • Figure USA Thebaine Production Share by Regions in 2027

    • Table USA Thebaine Consumption by Regions

    • Table USA Thebaine Consumption Share by Regions

    • Figure USA Thebaine Consumption Share by Regions in 2016

    • Figure USA Thebaine Consumption Share by Regions in 2021

    • Figure USA Thebaine Consumption Share by Regions in 2027

    • Table West USA Thebaine Consumption by Types from 2016 to 2027

    • Table West USA Thebaine Consumption Share by Types from 2016 to 2027

    • Figure West USA Thebaine Consumption Share by Types in 2016

    • Figure West USA Thebaine Consumption Share by Types in 2021

    • Figure West USA Thebaine Consumption Share by Types in 2027

    • Table West USA Thebaine Consumption by End-Users from 2016 to 2027

    • Table West USA Thebaine Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Thebaine Consumption Share by End-Users in 2016

    • Figure West USA Thebaine Consumption Share by End-Users in 2021

    • Figure West USA Thebaine Consumption Share by End-Users in 2027

    • Table South USA Thebaine Consumption by Types from 2016 to 2027

    • Table South USA Thebaine Consumption Share by Types from 2016 to 2027

    • Figure South USA Thebaine Consumption Share by Types in 2016

    • Figure South USA Thebaine Consumption Share by Types in 2021

    • Figure South USA Thebaine Consumption Share by Types in 2027

    • Table South USA Thebaine Consumption by End-Users from 2016 to 2027

    • Table South USA Thebaine Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Thebaine Consumption Share by End-Users in 2016

    • Figure South USA Thebaine Consumption Share by End-Users in 2021

    • Figure South USA Thebaine Consumption Share by End-Users in 2027

    • Table Middle West USA Thebaine Consumption by Types from 2016 to 2027

    • Table Middle West USA Thebaine Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Thebaine Consumption Share by Types in 2016

    • Figure Middle West USA Thebaine Consumption Share by Types in 2021

    • Figure Middle West USA Thebaine Consumption Share by Types in 2027

    • Table Middle West USA Thebaine Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Thebaine Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Thebaine Consumption Share by End-Users in 2016

    • Figure Middle West USA Thebaine Consumption Share by End-Users in 2021

    • Figure Middle West USA Thebaine Consumption Share by End-Users in 2027

    • Table Northeast USA Thebaine Consumption by Types from 2016 to 2027

    • Table Northeast USA Thebaine Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Thebaine Consumption Share by Types in 2016

    • Figure Northeast USA Thebaine Consumption Share by Types in 2021

    • Figure Northeast USA Thebaine Consumption Share by Types in 2027

    • Table Northeast USA Thebaine Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Thebaine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Thebaine Consumption Share by End-Users in 2016

    • Figure Northeast USA Thebaine Consumption Share by End-Users in 2021

    • Figure Northeast USA Thebaine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Taj Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taj Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Taj Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Taj Pharmaceuticals

    • Table Product and Service Introduction of Taj Pharmaceuticals

    • Table Company Profile and Development Status of API Labs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of API Labs

    • Figure Sales and Growth Rate Analysis of API Labs

    • Figure Revenue and Market Share Analysis of API Labs

    • Table Product and Service Introduction of API Labs

    • Table Company Profile and Development Status of Alcaliber

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alcaliber

    • Figure Sales and Growth Rate Analysis of Alcaliber

    • Figure Revenue and Market Share Analysis of Alcaliber

    • Table Product and Service Introduction of Alcaliber

    • Table Company Profile and Development Status of Tasmanian Alkaloids

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tasmanian Alkaloids

    • Figure Sales and Growth Rate Analysis of Tasmanian Alkaloids

    • Figure Revenue and Market Share Analysis of Tasmanian Alkaloids

    • Table Product and Service Introduction of Tasmanian Alkaloids

    • Table Company Profile and Development Status of TPI

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TPI

    • Figure Sales and Growth Rate Analysis of TPI

    • Figure Revenue and Market Share Analysis of TPI

    • Table Product and Service Introduction of TPI

    • Table Company Profile and Development Status of Cepia-Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepia-Sanofi

    • Figure Sales and Growth Rate Analysis of Cepia-Sanofi

    • Figure Revenue and Market Share Analysis of Cepia-Sanofi

    • Table Product and Service Introduction of Cepia-Sanofi

    • Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals

    • Table Product and Service Introduction of Mallinckrodt Pharmaceuticals

    • Table Company Profile and Development Status of Noramco

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Noramco

    • Figure Sales and Growth Rate Analysis of Noramco

    • Figure Revenue and Market Share Analysis of Noramco

    • Table Product and Service Introduction of Noramco

    • Table Company Profile and Development Status of Faran Shimi Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Faran Shimi Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Faran Shimi Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Faran Shimi Pharmaceuticals

    • Table Product and Service Introduction of Faran Shimi Pharmaceuticals

    • Table Company Profile and Development Status of Gansu Alkaloids

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gansu Alkaloids

    • Figure Sales and Growth Rate Analysis of Gansu Alkaloids

    • Figure Revenue and Market Share Analysis of Gansu Alkaloids

    • Table Product and Service Introduction of Gansu Alkaloids

    • Table Company Profile and Development Status of Hwells

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hwells

    • Figure Sales and Growth Rate Analysis of Hwells

    • Figure Revenue and Market Share Analysis of Hwells

    • Table Product and Service Introduction of Hwells


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.